Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 427-432

  Jin, Hekun ^a,b   Tucker, Susan L ^c   Liu, Hui Helen ^c   Wei, Xiong ^c   Yom, Sue Sun ^c   Wang, Shulian ^d   Komaki, Ritsuko ^c   Chen, Yuhchyau ^e   Martel, Mary K ^c   Mohan, Radhe ^c   Cox, James D ^c   Liao, Zhongxing ^c  

^a HUNAN CANCER HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d CANCER HOSPITAL   (China)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Dose volume histogram; Non small cell lung cancer; Smoking; Treatment related pneumonitis

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; DOSIMETRY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 65749104089     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.09.009     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Robnett T.J., Machtay M., Vines E.F., et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 89-94
3. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 67 (2003) 275-283
4. Yamada M., Kudoh S., Hirata K., et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 34 (1998) 71-75
5. Roach III M., Gandara D., Yuo H., et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 13 (1995) 2606-2612
6. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
7. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
8. Kwa S., Lebesque J., Theuws J., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
9. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
10. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
11. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215
12. Willner J., Jost A., Baier K., et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179 (2003) 548-556
13. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 3 (1994) 575-581
14. Graham M., Purdy J., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
15. Chen Y., Rubin P., Williams J., et al. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49 (2001) 641-648
16. Tsujii M., and DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83 (1995) 493-501
17. Armstrong J., Zelefsky M., Leibel S., et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 6 (1995) 693-697
18. Fay M., Tan A., Fisher R., et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1355-1363
19. Wang S., Liao Z., Vaporciyan A., et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64 (2006) 692-699
20. Yom S.S., Liao Z., Liu H.H., et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 94-102
21. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
22. Bjermer L., Cai Y., Nilsson K., et al. Tobacco smoke exposure suppresses radiation-induced inflammation in the lung: a study of bronchoalveolar lavage and ultrastructural morphology in the rat. Eur Respir J 6 (1993) 1173-1180
23. Nilsson K., Henriksson R., Cai Y.Q., et al. Effects of tobacco-smoke on radiation-induced pneumonitis in rats. Int J Radiat Biol 62 (1992) 719-727
24. Laviolette M., Coulombe R., Picard S., et al. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J Clin Invest 77 (1986) 54-60
25. Ferson M., Edwards A., Lind A., et al. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 23 (1979) 603-609
26. Bhattathiri V.N. Possible role of plasma GSH in modulating smoking related radiation pneumonitis. Radiother Oncol 51 (1999) 291-292
27. Sun S., Schiller J.H., and Gazdar A.F. Lung cancer in never smokers - a different disease. Natl Rev Cancer 7 (2007) 778-790
28. Doerr W., Bertmann S., Herrmann T., et al. Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects. Strahlenther Onkol 181 (2005) 567-573
29. Wang S., Liao Z., Wei X., et al. Association between systemic chemotherapy prior to chemoradiation and increased risk of treatment related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 3 (2008) 277-282